Seymour JF - Search Results

1

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B. Grever MR, et al. Among authors: seymour jf. Blood. 2017 Feb 2;129(5):553-560. doi: 10.1182/blood-2016-01-689422. Epub 2016 Nov 30. Blood. 2017. PMID: 27903528 Free PMC article.

2

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.

Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R. Cortes JE, et al. Among authors: seymour jf. Blood. 1995 May 1;85(9):2516-20. Blood. 1995. PMID: 7537119 Free article.

3

Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.

Seymour JF, Estey EH, Keating MJ, Kurzrock R. Seymour JF, et al. Leukemia. 1995 May;9(5):929-32. Leukemia. 1995. PMID: 7769859

4

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia.

Seymour JF, Kurzrock R, Freireich EJ, Estey EH. Seymour JF, et al. Blood. 1994 May 15;83(10):2906-11. Blood. 1994. PMID: 7910051 Free article.

5

Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.

Seymour JF, Talpaz M, Kurzrock R. Seymour JF, et al. Leukemia. 1997 Jan;11(1):42-7. doi: 10.1038/sj.leu.2400513. Leukemia. 1997. PMID: 9001417

6

Diffuse large B-cell non-Hodgkin's lymphoma presenting as Sister Joseph's nodule.

Tam C, Turner H, Hicks RJ, Seymour JF. Tam C, et al. Among authors: seymour jf. Leuk Lymphoma. 2002 Oct;43(10):2055-7. doi: 10.1080/1042819021000016005. Leuk Lymphoma. 2002. PMID: 12481909 Review.

7

Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age.

Mileshkin L, Biagi JJ, Mitchell P, Underhill C, Grigg A, Bell R, McKendrick J, Briggs P, Seymour JF, Lillie K, Smith JG, Zeldis JB, Prince HM. Mileshkin L, et al. Among authors: seymour jf. Blood. 2003 Jul 1;102(1):69-77. doi: 10.1182/blood-2002-09-2846. Epub 2003 Mar 13. Blood. 2003. PMID: 12637329 Free article. Clinical Trial.

8

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Among authors: seymour jf. Cancer. 2004 May 15;100(10):2181-9. doi: 10.1002/cncr.20234. Cancer. 2004. PMID: 15139062 Free article. Review.

9

Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.

Tam CS, Prince HM, Westerman D, Seymour JF, Juneja S. Tam CS, et al. Among authors: seymour jf. Leuk Lymphoma. 2004 Apr;45(4):705-10. doi: 10.1080/10428190310001615657. Leuk Lymphoma. 2004. PMID: 15160943 Review.

10

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.

Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Tam CS, et al. Among authors: seymour jf. Am J Hematol. 2004 Sep;77(1):72-6. doi: 10.1002/ajh.20147. Am J Hematol. 2004. PMID: 15307110 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters